Re-inventing drug discovery by targeting biomolecular condensates

We gained exponential growth in technology over the past few decades, but the field of drug discovery has remained relatively stagnant. There is a need for re-inventing the drug discovery process with disruptive innovations. The term “disruptive innovation” first coined by Clayton M. Christensen in 1995, describes the innovations that significantly affect the way aContinue reading “Re-inventing drug discovery by targeting biomolecular condensates”